Denne side vedligeholdes ikke mere – se afløseren her.

Are All DOACs Created Equal for Managing Atrial Fibrillation?

New study: Yes, when it comes to efficacy. For safety, Apixaban (Eliquis) is associated with less GI bleedings, but since the absolute percentage of GI bleedings is 2-3,5%, it may only give a marginal clinical benefit to choose Apixaban over the other DOACs
jwatch.org/na55472/2022/11/08/
#dklæger #MedMastodon

Kommentarer

Skriv et svar

Din e-mailadresse vil ikke blive publiceret. Krævede felter er markeret med *